About us
Our Science
Lead Program
- IBC-Ab002 Antibody
- IBC-01-01 Clinical Trial
Pipeline
News
Contact Us

Menu

About us
Our Science
Lead Program
- IBC-Ab002 Antibody
- IBC-01-01 Clinical Trial
Pipeline
News
Contact Us

Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy

Overview
Our History
Leadership
Partnerships

Overview
Patents
Publications

IBC-Ab002 Antibody
IBC-01-01 Clinical Trial

Follow us

Terms of Use
Privacy Statement
FCOI
Cookies Statement

Terms of Use
Privacy Statement
FCOI
Cookies Statement

Copyright © 2023 Immunobrain. All Rights Reserved.

Design PortnovMishan